CN117280218A - 用于脓毒症的早期检测的strem1标志物组 - Google Patents

用于脓毒症的早期检测的strem1标志物组 Download PDF

Info

Publication number
CN117280218A
CN117280218A CN202280031694.8A CN202280031694A CN117280218A CN 117280218 A CN117280218 A CN 117280218A CN 202280031694 A CN202280031694 A CN 202280031694A CN 117280218 A CN117280218 A CN 117280218A
Authority
CN
China
Prior art keywords
biomarker
amount
subject
hbp
bilirubin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280031694.8A
Other languages
English (en)
Chinese (zh)
Inventor
F·格鲁内瓦尔德
V·J·R·杰格
M·克莱默
P·舒兹
M·冯霍尔蒂
S·韦伯
H·韦格迈尔
U-H·维恩休斯-泰伦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN117280218A publication Critical patent/CN117280218A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN202280031694.8A 2021-04-30 2022-04-29 用于脓毒症的早期检测的strem1标志物组 Pending CN117280218A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21171489.4 2021-04-30
EP21171489 2021-04-30
PCT/EP2022/061551 WO2022229421A2 (en) 2021-04-30 2022-04-29 Strem1 marker panels for early detection of sepsis

Publications (1)

Publication Number Publication Date
CN117280218A true CN117280218A (zh) 2023-12-22

Family

ID=75746431

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280031694.8A Pending CN117280218A (zh) 2021-04-30 2022-04-29 用于脓毒症的早期检测的strem1标志物组

Country Status (5)

Country Link
US (1) US20240230674A1 (https=)
EP (1) EP4330680A2 (https=)
JP (1) JP2024516678A (https=)
CN (1) CN117280218A (https=)
WO (1) WO2022229421A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025257393A1 (en) * 2024-06-14 2025-12-18 Roche Diagnostics Gmbh Method and system for improving biomarker based disease assessments

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2476597C (en) 2002-02-28 2011-05-17 Metanomics Gmbh & Co. Kgaa Mass spectrometry method for analysing mixtures of substances
GB0401730D0 (en) * 2004-01-27 2004-03-03 Bioxell Spa Diagnosis method
US20090197794A1 (en) 2005-07-13 2009-08-06 Aird William C Methods of Diagnosing and Treating an Inflammatory Response
AU2006299417A1 (en) * 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in Systemic Inflammatory Response Syndromes
GB0711327D0 (en) * 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
CN103123359B (zh) 2007-08-03 2015-07-29 B.R.A.H.M.S有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用
ES2506116T3 (es) * 2008-05-23 2014-10-13 Biocartis Nv Nuevo biomarcador para diagnóstico, predicción y/o pronóstico de septicemia y usos del mismo
US20110287433A1 (en) * 2008-10-28 2011-11-24 Didier Payen De La Garanderie Methods and Kits for the Rapid Determination of Patients at High Risk of Death During Severe Sepsis and Septic Shock
JP2012159356A (ja) * 2011-01-31 2012-08-23 Mochida Pharmaceut Co Ltd 敗血症診断用組合せマーカー
CN108802385B (zh) * 2012-02-09 2022-02-08 米密德诊断学有限公司 用于诊断感染的标记和决定因素和其使用方法
RU2016112915A (ru) 2013-09-05 2017-10-09 Эф-Ай-Оу Корпорейшн Биомаркеры для раннего выявления критической или угрожающей жизни ответной реакции на заболевание и/или ответной реакции на лечение

Also Published As

Publication number Publication date
WO2022229421A2 (en) 2022-11-03
US20240230674A1 (en) 2024-07-11
JP2024516678A (ja) 2024-04-16
WO2022229421A3 (en) 2022-12-08
EP4330680A2 (en) 2024-03-06

Similar Documents

Publication Publication Date Title
JP2026048754A (ja) 敗血症の早期検出用のｐｃｔマーカーパネル
CN117280218A (zh) 用于脓毒症的早期检测的strem1标志物组
CN117242350A (zh) 用于脓毒症的早期检测的il6标志物组
CN117295950A (zh) 用于脓毒症的早期检测的ngal标志物组
CN117203528A (zh) 用于脓毒症的早期检测的gdf15标志物组
CN117242349A (zh) 用于脓毒症的早期检测的igfbp7标志物组
CN117255947A (zh) 用于脓毒症的早期检测的sFlt1标志物组
CN117321419A (zh) 用于脓毒症的早期检测的Presepsin标志物组
CN117597584A (zh) 用于脓毒症的早期检测的esm1标志物组合
CN118043479A (zh) 用于脓毒症的早期检测的MR-proADM标志物组
CN118742814A (zh) 用于脓毒症的早期检测的dll1标志物组

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination